医学
生物标志物
前瞻性队列研究
内科学
肿瘤科
队列研究
精密医学
价值(数学)
队列
不利影响
重症监护医学
风险评估
梅德林
预测值
个性化医疗
生物信息学
试验预测值
预测模型
信息的价值
作者
Shanshan Liu,Jian Dong,Jia Hao Wu
标识
DOI:10.1080/14737159.2026.2651164
摘要
Background Effective risk stratification in community-acquired pneumonia (CAP) remains challenging. We evaluated soluble suppression of tumorigenicity 2 (sST2) dynamics for predicting 90-day all-cause mortality and hospital readmission.Methods Prospective cohort of 146 severe CAP, 135 mild CAP patients, and 50 controls. Serum sST2 measured at admission and pre-discharge. with dynamic changes (ΔsST2 = T2 - T1) calculated. The primary endpoints were 90-day all-cause mortality and 90-day all-cause readmission, Predictive models 1for each endpoint, including sST2-based and traditional clinical scores, were compared using area under the receiver operating characteristic curve (AUC), Brier score, and decision curve analysis (DCA).Results Admission sST2 distinguished severity (AUC = 0.780). A pre-discharge model (sST2, D-dimer, lymphocyte percentage) predicted mortality superiorly (AUC = 0.79) versus clinical scores (PSI:0.69, p = 0.038; SOFA:0.66, p = 0.015). Admission sST2 independently predicted mortality (HR = 1.89, p = 0.003).High sST2 strongly predicted readmission at both T1 and T2. especially in the early to intermediate follow-up period.Conclusions sST2 dynamics significantly enhance CAP risk stratification. The discharge-phase biomarker model outperforms conventional scores,a model using D-dimer, procalcitonin, and lymphocyte percentage is a practical alternative. Integrating recovery-phase biomarkers into discharge planning offers a precision medicine strategy to optimize post-discharge management and reduce adverse outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI